NYSE: BLXBladex Inc Stock
$53.43+0.17 (+0.32%)
Updated Aug 21, 2026
BLX Price
$53.43
Fair Value Price
N/A
Market Cap
$1.99B
52 Week Low
$38.41
52 Week High
$63.20
P/E
8.74x
P/B
1.18x
P/S
4.88x
PEG
1.04x
Dividend Yield
3.86%
Revenue
$339.57M
Earnings
$226.88M
Gross Margin
100%
Operating Margin
66.81%
Profit Margin
66.8%
Debt to Equity
6.62
Operating Cash Flow
$504M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
Aug 25, 2026
BLX Overview
Foreign Trade Bank Of Latin America, Inc. is a commercial banks that operates in Latin America and the Caribbean, primarily for the purpose of financing foreign trade in those regions. Formerly known as Banco Latinoamericano de Comercio Exterior, S.A., the bank was founded in 1977 and is headquartered in Panama City, Panama.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BLX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
BLX
Ranked#85 of 286
Ranked#85 of 286
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $72.84 | A | |
| $25.80 | B | |
| $46.68 | B |
Be the first to know about important BLX news, forecast changes, insider trades & much more!
BLX News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BLX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BLX ($53.43) is trading above its intrinsic value of $47.22, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BLX is good value based on its earnings relative to its share price (8.74x), compared to the US market average (18.35x)
P/E vs Market Valuation
BLX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BLX due diligence checks available for Premium users.
Valuation
BLX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.74x
Industry
14.13x
Market
18.35x
BLX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BLX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BLX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.18x
Industry
1.31x
BLX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BLX price to earnings growth (PEG)
For valuing profitable companies with growth potential
BLX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
BLX's financial health
Profit margin
Revenue
$339.6M
Net Income
$226.9M
Profit Margin
66.8%
BLX's Earnings (EBIT) of $226.88M... subscribe to Premium to read more.
Interest Coverage Financials
BLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.8B
Liabilities
$11.1B
Debt to equity
6.62
BLX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$503.9M
Investing
-$211.2M
Financing
-$546.8M
BLX's operating cash flow ($503.87M)... subscribe to Premium to read more.
Debt Coverage Financials
BLX vs Bank Stocks
Bladex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.